丝袜脚交免费网站xx-国产91丝袜在线播放-国产视频一区二区三区在线观看-午夜美女视频-午夜爽爽视频-制服丝袜先锋影音-天天躁日日躁狠狠躁喷水-日韩综合一区二区三区-99思思-日本体内she精视频-欧美精品免费播放-日韩欧美国产不卡-一级在线免费观看视频-韩国午夜理伦三级在线观看按摩房-伦乱激情视频

Scientists develop new form of antibiotic to combat multidrug resistant bacteria

Source: Xinhua| 2018-09-28 12:22:28|Editor: Li Xia
Video PlayerClose

SYDNEY, Sept. 28 (Xinhua) -- A new antibiotic, developed by an Australian led-team of scientists, revealed on Friday, could present a solution to the problem of drug resistant bacteria, which is expected to present an ever increasing concern in the coming century.

The new kind of antibiotic was developed to limit multidrug resistance by targeting and disrupting key elements in bacterial cells, by scientists from Griffith University (GU), in collaboration with colleagues from Queensland University of Technology, the United States' Indiana University and China's Dezhou University.

"We tried to develop a new type of antibiotics that act differently than what we are using right now," Professor Yaoqi Zhou from GU's Institute for Glycomics told Xinhua.

"The way most antibiotics stop key functions in bacteria is that they bind to the surface of an essential protein so that it is unable to perform its normal function."

"Our technique with this new antibiotic approach is different -- instead of binding to the surface of the protein, we disrupt the structure of the protein, which stops it functioning."

In one test Zhou said, the team saw a 500-fold resistance develop to a commonly used antibiotic over 30 days, where as their newly developed antibiotic encountered no developed resistance at all.

Additionally the new drug may be useful in cancer treatment, another area where drug resistance is a major hurdle.

"What we've found in the concept is that it's not only working for antibiotics but should also work for anti-cancer, which also has a lot of problems in terms of drug resistance, also anti-viral - viral infections have a lot of problems with anti-drug resistance," Zhou said.

"So I think this is a concept that should be useful for any other kinds of disease which also has problems with drug resistance issues."

Although still in the early theoretical stage, Zhou is hopeful that the method will progress to animal testing and eventually clinical trials, and provide an answer to what is an increasingly urgent international crisis.

TOP STORIES
EDITOR’S CHOICE
MOST VIEWED
EXPLORE XINHUANET
010020070750000000000000011100001374987631